We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$8.21B
AUM Growth
+$1.17B
Cap. Flow
+$1.31B
Cap. Flow %
15.93%
Top 10 Hldgs %
19.59%
Holding
1,801
New
278
Increased
701
Reduced
627
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 19.89%
2 Financials 9.29%
3 Industrials 9.2%
4 Healthcare 6.57%
5 Communication Services 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GENI icon
1651
Genius Sports
GENI
$1.72B
$82.6K ﹤0.01%
18,650
-2,600
-12% -$18.5K
OGN icon
1652
Organon & Co
OGN
$3.56B
$79.4K ﹤0.01%
13,248
-376
-3% -$2.83K
OCGN icon
1653
Ocugen
OCGN
$430M
$79.3K ﹤0.01%
43,805
WEN icon
1654
Wendy's
WEN
$1.37B
$71.5K ﹤0.01%
+10,281
New +$79.1K
COYA icon
1655
Coya Therapeutics
COYA
$103M
$70.9K ﹤0.01%
18,000
+4,000
+29% +$18.7K
TV icon
1656
Televisa
TV
$1.47B
$70.9K ﹤0.01%
24,361
TCPC icon
1657
BlackRock TCP Capital
TCPC
$263M
$58.8K ﹤0.01%
+16,300
New +$75.6K
NRO
1658
Neuberger Real Estate Securities Income Fund Inc
NRO
$190M
$56.5K ﹤0.01%
19,903
+595
+3% +$1.78K
MGF
1659
Aberdeen Government Markets Income Fund
MGF
$91.6M
$56.5K ﹤0.01%
19,222
IGR
1660
CBRE Global Real Estate Income Fund
IGR
$696M
$52.7K ﹤0.01%
+12,009
New +$56.4K
EVTL icon
1661
Vertical Aerospace
EVTL
$192M
$49.7K ﹤0.01%
22,500
+1,000
+5% +$4.55K
SNAP icon
1662
Snap
SNAP
$7.42B
$47.8K ﹤0.01%
+10,387
New +$61.2K
DHY
1663
Credit Suisse High Yield Credit Fund
DHY
$242M
$47.5K ﹤0.01%
25,000
GRCE
1664
Grace Therapeutics
GRCE
$38.2M
$46.3K ﹤0.01%
+10,000
New +$39.3K
LRMR icon
1665
Larimar Therapeutics
LRMR
$417M
$45K ﹤0.01%
10,000
WIT icon
1666
Wipro
WIT
$17.6B
$44.5K ﹤0.01%
21,000
APPS icon
1667
Digital Turbine
APPS
$971M
$42.3K ﹤0.01%
14,695
-40
-0.3% -$172
BMBL icon
1668
Bumble
BMBL
$364M
$40.4K ﹤0.01%
12,400
+2,400
+24% +$7.98K
AIRJ
1669
Montana Technologies Corp
AIRJ
$324M
$39.1K ﹤0.01%
15,572
+223
+1% +$752
PSEC icon
1670
Prospect Capital
PSEC
$1.06B
$38.1K ﹤0.01%
14,617
-500
-3% -$1.37K
LXRX icon
1671
Lexicon Pharmaceuticals
LXRX
$1.02B
$36.7K ﹤0.01%
23,500
INAB icon
1672
IN8bio
INAB
$11.4M
$35.6K ﹤0.01%
+24,033
New +$46.5K
LUCD icon
1673
Lucid Diagnostics
LUCD
$180M
$34.5K ﹤0.01%
+30,000
New +$38.2K
NFGC
1674
New Found Gold
NFGC
$553M
$34K ﹤0.01%
17,500
+1,500
+9% +$4.03K
ALIT icon
1675
Alight
ALIT
$482M
$29.1K ﹤0.01%
+2,500
New +$59.6K

Similar funds

Oppenheimer & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Oppenheimer & Co held 1,801 positions worth $8.21B, up 17% from $7.04B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oppenheimer & Co deployed $1.31B of net new capital in Q1 2026, opening 278 new positions and adding to 701 existing holdings. Its largest new stake was Apple: 1,107,179 shares worth $281M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $11.2M trimmed.

  • Oppenheimer & Co's largest Q1 2026 buy was Apple: 1,107,179 shares worth $281M.
  • Oppenheimer & Co added most to Microsoft in Q1 2026, an estimated $24M increase.
  • Oppenheimer & Co's biggest Q1 2026 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $11.2M.
  • Oppenheimer & Co fully exited Telefonica in Q1 2026, selling an estimated $6.36M.
  • Oppenheimer & Co's ten largest holdings make up 20% of its $8.21B portfolio in Q1 2026.
  • Oppenheimer & Co opened 278 new positions and closed 118 in Q1 2026.
  • Oppenheimer & Co's portfolio value rose 17% quarter-over-quarter to $8.21B.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.